Open access peer-reviewed chapter

Anticancer Drug — Friend or Foe

By Tuğba Taşkın-Tok and Sivakumar Gowder

Submitted: January 24th 2014Reviewed: March 31st 2014Published: July 2nd 2014

DOI: 10.5772/58552

Downloaded: 2834

© 2014 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Tuğba Taşkın-Tok and Sivakumar Gowder (July 2nd 2014). Anticancer Drug — Friend or Foe, Pharmacology and Therapeutics Sivakumar Joghi Thatha Gowder, IntechOpen, DOI: 10.5772/58552. Available from:

Embed this chapter on your site Copy to clipboard

<iframe src="http://www.intechopen.com/embed/pharmacology-and-therapeutics/anticancer-drug-friend-or-foe" />

Embed this code snippet in the HTML of your website to show this chapter

chapter statistics

2834total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Drug Carrier Systems Using Chitosan for Non Parenteral Routes

By Clara Luisa Domínguez-Delgado, Isabel Marlen Rodríguez-Cruz, Enrique Fuentes-Prado, José Juan Escobar-Chávez, Gustavo Vidal- Romero, Lorena García-González and Rafael Iván Puente-Lee

Related Book

First chapter

Pre-Clinical Assessment of the Potential Intrinsic Hepatotoxicity of Candidate Drugs

By Jacob John van Tonder, Vanessa Steenkamp and Mary Gulumian

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

+3,550 Open Access Books

+57,400 Citations in Web of Science

+108,500 IntechOpen Authors and Academic Editors

+560,000 Unique visitors per month

More about us